🔗 Permalink

Inventor profile of:

Roberto Mariani

City:

San Diego, California

Country:

United States

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Roberto Mariani

The entities that hold a legal rights for patent applications filed by inventor Mariani Roberto:

AMBRX, INC. 17 La Jolla, CA United States
CALDER BIOSCIENCES INC. 3 NEW YORK, NY United States
Ambrx, Inc. 1 San Diego, CA United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HELATH 1 BETHESDA, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 1 Bethesda, MD United States

Recent patent applications by Mariani Roberto

Roberto Mariani from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250171500A1

Chemistry; metallurgy

CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS

#2 | 2022-04-21

US20220119454A1

Chemistry; metallurgy

Conformationally stabilized RSV pre-fusion F proteins

#3 | 2021-08-26

US20210261637A1

Chemistry; metallurgy

Modified FGF-21 polypeptides with non-naturally encoded amino acids

#4 | 2020-01-30

US20200031894A1

Chemistry; metallurgy

Modified FGF-21 polypeptides and their uses

#5 | 2019-09-26

US20190292228A1

Chemistry; metallurgy

CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS

#6 | 2018-10-18

US20180298073A1

Chemistry; metallurgy

Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses

#7 | 2017-04-06

US20170096463A1

Chemistry; metallurgy

Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids

#8 | 2015-10-01

US20150273075A1

Human necessities

Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

#9 | 2015-01-29

US20150030622A1

Chemistry; metallurgy

Conformationally stabilized RSV pre-fusion F proteins

#10 | 2013-09-12

US20130237474A1

Chemistry; metallurgy

Biosynthetic Polypeptide Fusion Inhibitors

#11 | 2013-06-13

US20130150564A1

Chemistry; metallurgy

Modified FGF-21 polypeptides comprising non-naturally occurring amino acids

#12 | 2012-06-07

US20120142890A1

Chemistry; metallurgy

Biosynthetic Polypeptide Fusion Inhibitors

#13 | 2011-07-14

US20110172401A1

Chemistry; metallurgy

Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

#14 | 2010-06-03

US20100135959A1

Chemistry; metallurgy

Human Interferon Molecules and Their Uses

#15 | 2010-02-25

US20100048871A1

Chemistry; metallurgy

Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids

#16 | 2009-04-02

US20090088365A1

Chemistry; metallurgy

Biosynthetic Polypeptide Fusion Inhibitors

#17 | 2008-10-16

US20080255045A1

Chemistry; metallurgy

Modified FGF-21 polypeptides and their uses

#18 | 2008-06-05

US20080132681A1

Chemistry; metallurgy

Pegylated human interferon polypeptides

#19 | 2008-05-22

US20080119640A1

Chemistry; metallurgy

Human Interferon Molecules and Their Uses

#20 | 2008-05-15

US20080113408A1

Chemistry; metallurgy

Biosynthetic Polypeptide Fusion Inhibitors

#21 | 2008-05-15

US20080112943A1

Chemistry; metallurgy

Biosynthetic Polypeptide Fusion Inhibitors

#22 | 2008-05-08

US20080108792A1

Chemistry; metallurgy

Human Interferon Molecules and Their Uses

#23 | 2006-01-26

US20060019347A1

Chemistry; metallurgy

Biosynthetic polypeptides utilizing non-naturally encoded amino acids

InventorID:

288288 ⎘